Cosimo Rasola

407 total citations
16 papers, 118 citations indexed

About

Cosimo Rasola is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cosimo Rasola has authored 16 papers receiving a total of 118 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cosimo Rasola's work include Colorectal Cancer Treatments and Studies (10 papers), Genetic factors in colorectal cancer (8 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Cosimo Rasola is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Genetic factors in colorectal cancer (8 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Cosimo Rasola collaborates with scholars based in Italy, France and United States. Cosimo Rasola's co-authors include Francesca Bergamo, Sara Lonardi, Beatrice Borelli, Giampaolo Tortora, Alessandra Boccaccino, Lisa Salvatore, Salvatore Corallo, Brunella Barbaro, Valentina Angerilli and Giovanni Randon and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Cosimo Rasola

15 papers receiving 117 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cosimo Rasola Italy 7 88 48 39 37 26 16 118
Jesper Nors Denmark 7 105 1.2× 37 0.8× 50 1.3× 62 1.7× 41 1.6× 15 175
Jane V. Thomas United States 5 87 1.0× 51 1.1× 48 1.2× 15 0.4× 34 1.3× 15 123
Emerik Österlund Sweden 5 103 1.2× 46 1.0× 21 0.5× 64 1.7× 32 1.2× 14 146
Iolanda Capone Italy 6 55 0.6× 31 0.6× 22 0.6× 29 0.8× 42 1.6× 16 109
Ayman Zawadi France 5 101 1.1× 76 1.6× 37 0.9× 25 0.7× 28 1.1× 13 132
Hiroki Yukami Japan 6 92 1.0× 85 1.8× 23 0.6× 104 2.8× 51 2.0× 20 152
Susan Preston Australia 5 56 0.6× 72 1.5× 15 0.4× 33 0.9× 12 0.5× 7 93
Sadhna Ahuja United States 2 62 0.7× 58 1.2× 16 0.4× 29 0.8× 9 0.3× 2 86
Maria Kuiper Netherlands 3 86 1.0× 38 0.8× 21 0.5× 12 0.3× 40 1.5× 5 104
Kalliope Valassiadou United Kingdom 7 75 0.9× 53 1.1× 69 1.8× 66 1.8× 9 0.3× 8 158

Countries citing papers authored by Cosimo Rasola

Since Specialization
Citations

This map shows the geographic impact of Cosimo Rasola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cosimo Rasola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cosimo Rasola more than expected).

Fields of papers citing papers by Cosimo Rasola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cosimo Rasola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cosimo Rasola. The network helps show where Cosimo Rasola may publish in the future.

Co-authorship network of co-authors of Cosimo Rasola

This figure shows the co-authorship network connecting the top 25 collaborators of Cosimo Rasola. A scholar is included among the top collaborators of Cosimo Rasola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cosimo Rasola. Cosimo Rasola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Rasola, Cosimo, Pierre Laurent‐Puig, Thierry André, et al.. (2023). Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer. European Journal of Cancer. 194. 113321–113321. 5 indexed citations
2.
Rasola, Cosimo, et al.. (2023). New developments and standard of care in the management of advanced gastric cancer. Clinics and Research in Hepatology and Gastroenterology. 48(1). 102245–102245. 8 indexed citations
3.
Prete, Alessandra Anna, Rossana Intini, Valentina Angerilli, et al.. (2023). Immunotherapy in RAS mutant mCRC: Could CTLA-4 blockade increase the efficacy of anti PD-1 agents? Preliminary clinical results of the NERDY study.. Journal of Clinical Oncology. 41(4_suppl). 218–218. 1 indexed citations
4.
Bergamo, Francesca, Eleonora Bergo, Francesca Daniel, et al.. (2022). The oncological multidimensional prognostic index is a promising decision-making tool: A real-world analysis in older patients with metastatic colorectal cancer. European Journal of Cancer. 177. 112–119. 4 indexed citations
5.
Angerilli, Valentina, Cosimo Rasola, Francesca Bergamo, et al.. (2022). Microsatellite Instable Colorectal Adenocarcinoma Diagnostics: The Advent of Liquid Biopsy Approaches. Frontiers in Oncology. 12. 930108–930108. 8 indexed citations
6.
7.
Bergamo, Francesca, Antonella Brunello, Giuseppe Sergi, et al.. (2022). 399P Role of geriatric assessment and oncological multidimensional prognostic index in elderly patients with metastatic colorectal cancer in a real-world setting. Annals of Oncology. 33. S719–S719.
9.
Prete, Alessandra Anna, Paolo Manca, Federica Morano, et al.. (2022). Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the “CARACAS” study.. Journal of Clinical Oncology. 40(4_suppl). 5–5. 1 indexed citations
10.
Prete, Alessandra Anna, Francesca Bergamo, Cosimo Rasola, et al.. (2022). An Unexpected Tumor Reduction: Treatment with Olaparib Monotherapy in Heavily Pretreated BRCA2 Mutated Metastatic Pancreatic Cancer. Current Oncology. 29(2). 544–550. 2 indexed citations
11.
Bergamo, Francesca, Francesca Daniel, Cosimo Rasola, et al.. (2021). A Real-World Application of Liquid Biopsy in Metastatic Colorectal Cancer: The Poseidon Study. Cancers. 13(20). 5128–5128. 12 indexed citations
12.
Moretto, Roberto, Daniele Rossini, Veronica Conca, et al.. (2021). CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies. British Journal of Cancer. 125(6). 839–845. 10 indexed citations
13.
Salvatore, Lisa, Maria Bensi, Salvatore Corallo, et al.. (2021). Phase II study of preoperative (PREOP) chemoradiotherapy (CTRT) plus avelumab (AVE) in patients (PTS) with locally advanced rectal cancer (LARC): The AVANA study.. Journal of Clinical Oncology. 39(15_suppl). 3511–3511. 42 indexed citations
14.
Salvatore, Lisa, Maria Bensi, Salvatore Corallo, et al.. (2021). O-12 Phase II study of preoperative chemoradiotherapy plus avelumab in patients with locally advanced rectal cancer: The AVANA study. Annals of Oncology. 32. S223–S223. 7 indexed citations
15.
Lonardi, Sara, Filippo Pietrantonio, Alessandra Anna Prete, et al.. (2020). Randomized phase II trial of avelumab alone or with cetuximab for unresectable, locally advanced or metastatic squamous cell anal carcinoma progressed to at least one line of treatment: The CARACAS study.. Journal of Clinical Oncology. 38(15_suppl). 4051–4051. 1 indexed citations
16.
Dedja, Arben, Massimo A. Padalino, Mila Della Barbera, et al.. (2017). Heterotopic Implantation of Decellularized Pulmonary Artery Homografts In A Rodent Model: Technique Description and Preliminary Report. Journal of Investigative Surgery. 31(4). 282–291. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026